| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | insulin receptor activity | 3.32e-05 | 3 | 67 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | myosin binding | 1.91e-04 | 85 | 67 | 4 | GO:0017022 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 4.48e-10 | 5 | 65 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.90e-06 | 65 | 65 | 5 | GO:0072132 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 DCAF4L2 RPAP1 PIK3R6 KLHL7 PYCARD POLR2B RGPD3 INSR INSRR SOCS1 ZSWIM4 | 3.59e-05 | 963 | 65 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | filopodium | 4.05e-05 | 123 | 65 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | insulin receptor complex | 5.69e-05 | 4 | 65 | 2 | GO:0005899 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 6.96e-05 | 576 | 65 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 8.00e-05 | 335 | 65 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | cell leading edge | 1.55e-04 | 500 | 65 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | dynactin complex | 2.63e-04 | 8 | 65 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.63e-04 | 8 | 65 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 3.46e-04 | 107 | 65 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 3.46e-04 | 107 | 65 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.22e-04 | 10 | 65 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | actomyosin | 4.85e-04 | 117 | 65 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 5.01e-04 | 118 | 65 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.46e-04 | 14 | 65 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.41e-03 | 18 | 65 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.73e-03 | 278 | 65 | 5 | GO:0098858 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.74e-03 | 20 | 65 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.92e-03 | 21 | 65 | 2 | GO:0106068 | |
| GeneOntologyCellularComponent | neuron projection membrane | 2.13e-03 | 82 | 65 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | azurophil granule lumen | 2.87e-03 | 91 | 65 | 3 | GO:0035578 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex | 3.66e-03 | 29 | 65 | 2 | GO:0005942 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.15e-03 | 210 | 65 | 4 | GO:0031256 | |
| Domain | Actin | 1.16e-09 | 31 | 67 | 6 | IPR004000 | |
| Domain | Actin | 1.16e-09 | 31 | 67 | 6 | PF00022 | |
| Domain | ACTIN | 1.16e-09 | 31 | 67 | 6 | SM00268 | |
| Domain | Actin_CS | 2.16e-09 | 16 | 67 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 3.05e-09 | 17 | 67 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.22e-09 | 18 | 67 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.71e-09 | 19 | 67 | 5 | PS01132 | |
| Domain | ACTINS_1 | 1.05e-08 | 8 | 67 | 4 | PS00406 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 3.79e-05 | 3 | 67 | 2 | IPR016246 | |
| Domain | Furin-like | 2.63e-04 | 7 | 67 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.63e-04 | 7 | 67 | 2 | IPR000494 | |
| Domain | GCC2_Rab_bind | 2.63e-04 | 7 | 67 | 2 | IPR032023 | |
| Domain | Furin-like_Cys-rich_dom | 2.63e-04 | 7 | 67 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 2.63e-04 | 7 | 67 | 2 | PF01030 | |
| Domain | Rab_bind | 2.63e-04 | 7 | 67 | 2 | PF16704 | |
| Domain | - | 2.63e-04 | 7 | 67 | 2 | 3.80.20.20 | |
| Domain | - | 5.60e-04 | 10 | 67 | 2 | 1.10.220.60 | |
| Domain | Grip | 6.83e-04 | 11 | 67 | 2 | SM00755 | |
| Domain | GRIP | 6.83e-04 | 11 | 67 | 2 | PF01465 | |
| Domain | Tyr_kinase_rcpt_2_CS | 6.83e-04 | 11 | 67 | 2 | IPR002011 | |
| Domain | Ran_BP1 | 8.18e-04 | 12 | 67 | 2 | PF00638 | |
| Domain | GRIP_dom | 8.18e-04 | 12 | 67 | 2 | IPR000237 | |
| Domain | RECEPTOR_TYR_KIN_II | 8.18e-04 | 12 | 67 | 2 | PS00239 | |
| Domain | GRIP | 8.18e-04 | 12 | 67 | 2 | PS50913 | |
| Domain | RANBD1 | 8.18e-04 | 12 | 67 | 2 | PS50196 | |
| Domain | RanBD | 9.64e-04 | 13 | 67 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 9.64e-04 | 13 | 67 | 2 | IPR000156 | |
| Domain | - | 1.20e-03 | 222 | 67 | 5 | 1.25.10.10 | |
| Domain | Furin_repeat | 1.87e-03 | 18 | 67 | 2 | IPR006212 | |
| Domain | FU | 1.87e-03 | 18 | 67 | 2 | SM00261 | |
| Domain | ARM-like | 2.83e-03 | 270 | 67 | 5 | IPR011989 | |
| Domain | TyrKc | 3.90e-03 | 88 | 67 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.90e-03 | 88 | 67 | 3 | IPR020635 | |
| Domain | FERM_C | 4.20e-03 | 27 | 67 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 4.20e-03 | 27 | 67 | 2 | IPR018980 | |
| Domain | FERM_N | 6.23e-03 | 33 | 67 | 2 | PF09379 | |
| Domain | FERM_N | 6.23e-03 | 33 | 67 | 2 | IPR018979 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.74e-05 | 47 | 47 | 4 | M39829 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 2.00e-10 | 6 | 68 | 4 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 2.00e-10 | 6 | 68 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 2.00e-10 | 6 | 68 | 4 | 11709093 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 2.00e-10 | 6 | 68 | 4 | 9971772 | |
| Pubmed | 2.00e-10 | 6 | 68 | 4 | 10049817 | ||
| Pubmed | 2.00e-10 | 6 | 68 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 2.00e-10 | 6 | 68 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 2.00e-10 | 6 | 68 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 2.00e-10 | 6 | 68 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 2.00e-10 | 6 | 68 | 4 | 8661406 | |
| Pubmed | 2.00e-10 | 6 | 68 | 4 | 23017337 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 2.00e-10 | 6 | 68 | 4 | 10074138 | |
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 2.00e-10 | 6 | 68 | 4 | 23875777 | |
| Pubmed | 2.00e-10 | 6 | 68 | 4 | 9841925 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 4.66e-10 | 7 | 68 | 4 | 17504171 | |
| Pubmed | 4.66e-10 | 7 | 68 | 4 | 22535526 | ||
| Pubmed | 4.66e-10 | 7 | 68 | 4 | 22465675 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 4.66e-10 | 7 | 68 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 4.66e-10 | 7 | 68 | 4 | 22640593 | |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 8.05e-10 | 23 | 68 | 5 | 22004035 | |
| Pubmed | 9.30e-10 | 8 | 68 | 4 | 14694110 | ||
| Pubmed | 9.30e-10 | 8 | 68 | 4 | 20147394 | ||
| Pubmed | 9.30e-10 | 8 | 68 | 4 | 23260110 | ||
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.67e-09 | 9 | 68 | 4 | 8892894 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 1.67e-09 | 9 | 68 | 4 | 10556093 | |
| Pubmed | 1.67e-09 | 9 | 68 | 4 | 18775311 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 2.78e-09 | 10 | 68 | 4 | 1991513 | |
| Pubmed | 2.78e-09 | 10 | 68 | 4 | 23575248 | ||
| Pubmed | 2.78e-09 | 10 | 68 | 4 | 1907279 | ||
| Pubmed | 4.36e-09 | 11 | 68 | 4 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 4.36e-09 | 11 | 68 | 4 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 4.36e-09 | 11 | 68 | 4 | 19639585 | |
| Pubmed | 4.75e-09 | 32 | 68 | 5 | 23369715 | ||
| Pubmed | 6.54e-09 | 12 | 68 | 4 | 23071112 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 7.15e-09 | 3 | 68 | 3 | 7780165 | |
| Pubmed | 1.32e-08 | 14 | 68 | 4 | 21923909 | ||
| Pubmed | 1.32e-08 | 14 | 68 | 4 | 17411366 | ||
| Pubmed | 3.12e-08 | 17 | 68 | 4 | 17360745 | ||
| Pubmed | 3.12e-08 | 17 | 68 | 4 | 8997639 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 9.52e-08 | 22 | 68 | 4 | 16526095 | |
| Pubmed | 1.93e-07 | 26 | 68 | 4 | 24742657 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 2.49e-07 | 7 | 68 | 3 | 9384381 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 30289203 | ||
| Pubmed | Interactions between the evolutionarily conserved, actin-related protein, Arp11, actin, and Arp1. | 2.49e-07 | 7 | 68 | 3 | 12857853 | |
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 20096780 | ||
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 5.95e-07 | 9 | 68 | 3 | 12297046 | |
| Pubmed | RGPD4 TDRD5 CSE1L RGPD3 ACTA1 ACTA2 ACTC1 ACTG2 MACF1 CTNND2 LDHA | 7.01e-07 | 844 | 68 | 11 | 25963833 | |
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 8.49e-07 | 10 | 68 | 3 | 21749862 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 22207710 | ||
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 1.55e-06 | 12 | 68 | 3 | 31042497 | |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 2.02e-06 | 13 | 68 | 3 | 18400219 | |
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 24598388 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8916919 | ||
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 3.77e-06 | 2 | 68 | 2 | 19468071 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20706863 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10559237 | ||
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 3.77e-06 | 2 | 68 | 2 | 1893870 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11463843 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10601340 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 3023046 | ||
| Pubmed | Muscle specific expression of Cre recombinase under two actin promoters in transgenic mice. | 3.77e-06 | 2 | 68 | 2 | 10686609 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 3075543 | ||
| Pubmed | Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. | 3.77e-06 | 2 | 68 | 2 | 9114002 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 2731651 | ||
| Pubmed | A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. | 3.77e-06 | 2 | 68 | 2 | 6897014 | |
| Pubmed | Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. | 3.93e-06 | 16 | 68 | 3 | 16638982 | |
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 3.93e-06 | 16 | 68 | 3 | 9799237 | |
| Pubmed | ACTR1A ZNF346 FBLL1 DSG2 TRIP6 DROSHA FARP1 POLR2B RGPD3 INTS15 MACF1 DAAM1 CTNND2 | 5.69e-06 | 1497 | 68 | 13 | 31527615 | |
| Pubmed | 5.71e-06 | 18 | 68 | 3 | 24840128 | ||
| Pubmed | 5.71e-06 | 18 | 68 | 3 | 15929941 | ||
| Pubmed | 6.77e-06 | 19 | 68 | 3 | 30700554 | ||
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 6.77e-06 | 19 | 68 | 3 | 18316483 | |
| Pubmed | 9.15e-06 | 247 | 68 | 6 | 30713523 | ||
| Pubmed | 9.27e-06 | 21 | 68 | 3 | 20230754 | ||
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 9.27e-06 | 21 | 68 | 3 | 23063798 | |
| Pubmed | Insulin receptor-related receptor as an extracellular alkali sensor. | 1.13e-05 | 3 | 68 | 2 | 21641549 | |
| Pubmed | Bmp2 regulates the interaction between EPDCs and myocytes in cardiac OFT. | 1.13e-05 | 3 | 68 | 2 | 22647617 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11342531 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22855565 | ||
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 1.13e-05 | 3 | 68 | 2 | 1728592 | |
| Pubmed | Molecular analysis of smooth muscle development in the mouse. | 1.13e-05 | 3 | 68 | 2 | 8573719 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12119014 | ||
| Pubmed | Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma. | 1.13e-05 | 3 | 68 | 2 | 14507647 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12554937 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21681845 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 3842206 | ||
| Pubmed | Morphology of the developing muscularis externa in the mouse esophagus. | 1.13e-05 | 3 | 68 | 2 | 21595780 | |
| Pubmed | The role of different Scinderin domains in the control of F-actin cytoskeleton during exocytosis. | 1.13e-05 | 3 | 68 | 2 | 12438125 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 3084797 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 6641707 | ||
| Pubmed | RGPD4 CSE1L TENM4 FARP1 RGPD3 MACF1 DAAM1 CTNND2 LDHA BIRC6 SHISA6 | 1.23e-05 | 1139 | 68 | 11 | 36417873 | |
| Pubmed | 1.23e-05 | 23 | 68 | 3 | 28923684 | ||
| Pubmed | 1.32e-05 | 399 | 68 | 7 | 37536630 | ||
| Pubmed | 1.55e-05 | 271 | 68 | 6 | 26816005 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 11812134 | ||
| Pubmed | Phosphorylation of spinophilin modulates its interaction with actin filaments. | 2.25e-05 | 4 | 68 | 2 | 12417592 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 2201580 | ||
| Pubmed | Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. | 2.25e-05 | 4 | 68 | 2 | 16127460 | |
| Pubmed | Interaction between protein kinase C and actin in megakaryocyte polyploidization. | 2.25e-05 | 4 | 68 | 2 | 10628374 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21949750 | ||
| Interaction | POTEJ interactions | 7.45e-07 | 52 | 66 | 5 | int:POTEJ | |
| Interaction | ABRA interactions | 5.71e-06 | 36 | 66 | 4 | int:ABRA | |
| Interaction | ACTG2 interactions | 1.99e-05 | 49 | 66 | 4 | int:ACTG2 | |
| Interaction | CLIP1 interactions | 2.99e-05 | 183 | 66 | 6 | int:CLIP1 | |
| GeneFamily | Actins | 3.76e-10 | 6 | 42 | 4 | 929 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 1.21e-06 | 26 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 1.65e-06 | 28 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 1.27e-05 | 15 | 66 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 1.49e-05 | 48 | 66 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 1.76e-05 | 50 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200 | 1.89e-05 | 17 | 66 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 2.68e-05 | 19 | 66 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 6.32e-05 | 69 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200 | 7.95e-05 | 27 | 66 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 9.71e-05 | 77 | 66 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 1.21e-04 | 31 | 66 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 1.30e-04 | 83 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_100 | 1.33e-04 | 32 | 66 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 1.49e-04 | 86 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 1.49e-04 | 86 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 1.63e-04 | 88 | 66 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.94e-04 | 92 | 66 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.07e-04 | 37 | 66 | 3 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 2.42e-04 | 39 | 66 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.47e-04 | 98 | 66 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_100 | 3.38e-04 | 9 | 66 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 3.45e-04 | 107 | 66 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_500 | 4.22e-04 | 47 | 66 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_500 | 4.54e-04 | 115 | 66 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 4.54e-04 | 115 | 66 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-07 | 166 | 68 | 6 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-07 | 166 | 68 | 6 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-07 | 176 | 68 | 6 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 173 | 68 | 5 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 173 | 68 | 5 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.66e-06 | 186 | 68 | 5 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 195 | 68 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 68 | 5 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 68 | 5 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.27e-05 | 197 | 68 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | CV-Moderate|CV / Virus stimulation, Condition and Cluster | 1.27e-05 | 197 | 68 | 5 | 8747a57ded96175a8365f066101ce2af80c8081d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 68 | 5 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 1.27e-05 | 197 | 68 | 5 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 198 | 68 | 5 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 198 | 68 | 5 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-05 | 152 | 68 | 4 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 153 | 68 | 4 | 1440f2716fea74e2c3eb2924eba3d63ebd08c997 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-05 | 155 | 68 | 4 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-05 | 155 | 68 | 4 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 162 | 68 | 4 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-04 | 163 | 68 | 4 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 166 | 68 | 4 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 167 | 68 | 4 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 170 | 68 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 170 | 68 | 4 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 170 | 68 | 4 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 171 | 68 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 171 | 68 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 175 | 68 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 176 | 68 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 177 | 68 | 4 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 177 | 68 | 4 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.58e-04 | 178 | 68 | 4 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 180 | 68 | 4 | de87503d9caac3ebc80ab8090c1a9ee5a925b2a0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 181 | 68 | 4 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 181 | 68 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 181 | 68 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-04 | 181 | 68 | 4 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 182 | 68 | 4 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 182 | 68 | 4 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.76e-04 | 183 | 68 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-04 | 183 | 68 | 4 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 183 | 68 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.80e-04 | 184 | 68 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.80e-04 | 184 | 68 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-04 | 184 | 68 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-04 | 185 | 68 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 1.91e-04 | 187 | 68 | 4 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.95e-04 | 188 | 68 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 1.95e-04 | 188 | 68 | 4 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 190 | 68 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.03e-04 | 190 | 68 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 191 | 68 | 4 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 191 | 68 | 4 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 191 | 68 | 4 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-04 | 191 | 68 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 193 | 68 | 4 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 193 | 68 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.16e-04 | 193 | 68 | 4 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.16e-04 | 193 | 68 | 4 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 193 | 68 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 193 | 68 | 4 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 193 | 68 | 4 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 68 | 4 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 195 | 68 | 4 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.24e-04 | 195 | 68 | 4 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.24e-04 | 195 | 68 | 4 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 195 | 68 | 4 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.24e-04 | 195 | 68 | 4 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 2.24e-04 | 195 | 68 | 4 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 2.29e-04 | 196 | 68 | 4 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.29e-04 | 196 | 68 | 4 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.29e-04 | 196 | 68 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.29e-04 | 196 | 68 | 4 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 196 | 68 | 4 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-04 | 196 | 68 | 4 | 20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 196 | 68 | 4 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 2.33e-04 | 197 | 68 | 4 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-04 | 197 | 68 | 4 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 2.33e-04 | 197 | 68 | 4 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 197 | 68 | 4 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 197 | 68 | 4 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-04 | 197 | 68 | 4 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 197 | 68 | 4 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 2.33e-04 | 197 | 68 | 4 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 197 | 68 | 4 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 197 | 68 | 4 | 090a251194da3e2806989d9a522588f83f52da7f | |
| Computational | Muscle genes. | 7.23e-06 | 37 | 37 | 4 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 2.25e-05 | 49 | 37 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 2.64e-05 | 51 | 37 | 4 | MODULE_329 | |
| Drug | Nsc687160 | 1.58e-09 | 18 | 67 | 5 | CID005459290 | |
| Drug | tolytoxin | 2.13e-09 | 19 | 67 | 5 | CID006440827 | |
| Drug | m2-19 | 2.13e-09 | 19 | 67 | 5 | CID000079129 | |
| Drug | AC1L9EF8 | 3.40e-09 | 79 | 67 | 7 | CID000443315 | |
| Drug | AC1L8NVR | 3.72e-09 | 21 | 67 | 5 | CID000384633 | |
| Drug | NSC312786 | 3.72e-09 | 21 | 67 | 5 | CID000329495 | |
| Drug | plakin | 4.42e-09 | 82 | 67 | 7 | CID000018752 | |
| Drug | CID5288653 | 1.77e-08 | 28 | 67 | 5 | CID005288653 | |
| Drug | azaspiracid | 2.55e-08 | 30 | 67 | 5 | CID006451158 | |
| Drug | AC1L1HS4 | 3.59e-08 | 32 | 67 | 5 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 4.94e-08 | 34 | 67 | 5 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 4.94e-08 | 34 | 67 | 5 | CID000001312 | |
| Drug | AC1NSKFN | 6.66e-08 | 36 | 67 | 5 | CID005311324 | |
| Drug | C3H2N2O3S | 8.18e-08 | 74 | 67 | 6 | CID000448652 | |
| Drug | AC1LD8HW | 8.87e-08 | 75 | 67 | 6 | CID000644061 | |
| Drug | epsilon-ATP | 1.31e-07 | 41 | 67 | 5 | CID000162262 | |
| Drug | AC1L8FNU | 1.88e-07 | 44 | 67 | 5 | CID000425429 | |
| Drug | AC1L22RD | 2.83e-07 | 91 | 67 | 6 | CID000065183 | |
| Drug | NpCaM | 2.94e-07 | 48 | 67 | 5 | CID000122259 | |
| Drug | AC1Q6LQU | 2.94e-07 | 48 | 67 | 5 | CID000072380 | |
| Drug | NSC106399 | 4.01e-07 | 51 | 67 | 5 | CID000002887 | |
| Drug | 3-methylhistidine | 5.88e-07 | 55 | 67 | 5 | CID000064969 | |
| Drug | beryllium fluoride | 5.91e-07 | 103 | 67 | 6 | CID000024589 | |
| Drug | dihydrocytochalasin B | 7.70e-07 | 58 | 67 | 5 | CID000003064 | |
| Drug | oryzalin | 1.17e-06 | 63 | 67 | 5 | CID000029393 | |
| Drug | 1tjp | 1.19e-06 | 116 | 67 | 6 | CID005459371 | |
| Drug | protocatechuic acid | 1.38e-06 | 119 | 67 | 6 | CID000000072 | |
| Drug | phenylarsine oxide | 1.44e-06 | 275 | 67 | 8 | CID000004778 | |
| Drug | 5-IAF | 1.47e-06 | 66 | 67 | 5 | CID000123822 | |
| Drug | AC1OAGKW | 1.60e-06 | 193 | 67 | 7 | CID006857413 | |
| Drug | AC1L1ERT | 1.84e-06 | 69 | 67 | 5 | CID000002920 | |
| Drug | AC1MNW2N | 1.98e-06 | 70 | 67 | 5 | CID003359490 | |
| Drug | caged ATP | 1.98e-06 | 70 | 67 | 5 | CID000123806 | |
| Drug | dl-Lysine | 2.14e-06 | 290 | 67 | 8 | CID000000866 | |
| Drug | microcystin-LR | 2.21e-06 | 129 | 67 | 6 | CID000445433 | |
| Drug | AC1OAGGW | 2.23e-06 | 203 | 67 | 7 | CID006857364 | |
| Drug | L-Carnosine | 2.44e-06 | 73 | 67 | 5 | CID000009369 | |
| Drug | AC1NRBPQ | 3.14e-06 | 137 | 67 | 6 | CID005288569 | |
| Drug | SIRIUS | 3.18e-06 | 77 | 67 | 5 | CID000091750 | |
| Drug | NSC60597 | 3.56e-06 | 140 | 67 | 6 | CID000003327 | |
| Drug | AC1NQAAM | 4.19e-06 | 144 | 67 | 6 | CID005192834 | |
| Drug | NSC 523214 | 4.72e-06 | 147 | 67 | 6 | CID000004752 | |
| Drug | PI(3,4,5)P3 | 4.91e-06 | 148 | 67 | 6 | CID000643963 | |
| Drug | formamide | 5.18e-06 | 85 | 67 | 5 | CID000000713 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 5.49e-06 | 86 | 67 | 5 | CID000000805 | |
| Drug | Formyl | 6.37e-06 | 238 | 67 | 7 | CID000123370 | |
| Drug | CaCl2 | 6.64e-06 | 156 | 67 | 6 | CID000024854 | |
| Drug | AC1NRCMD | 6.87e-06 | 90 | 67 | 5 | CID005289074 | |
| Drug | Epi Lovastatin | 7.05e-06 | 341 | 67 | 8 | CID000003962 | |
| Drug | C18:1n-7 | 7.65e-06 | 92 | 67 | 5 | CID000122325 | |
| Drug | cnicin | 7.65e-06 | 92 | 67 | 5 | CID000091176 | |
| Drug | mDia | 8.07e-06 | 93 | 67 | 5 | CID000128346 | |
| Drug | AC1L1GXW | 8.50e-06 | 94 | 67 | 5 | CID000003891 | |
| Drug | manidipine | 8.95e-06 | 95 | 67 | 5 | CID000004008 | |
| Drug | NSC3096 | 1.04e-05 | 98 | 67 | 5 | CID000002832 | |
| Drug | AC1L1BDQ | 1.20e-05 | 173 | 67 | 6 | CID000001394 | |
| Drug | sulphoxide | 1.21e-05 | 101 | 67 | 5 | CID000008442 | |
| Drug | etheno-NAD | 1.39e-05 | 104 | 67 | 5 | CID005288160 | |
| Drug | Ro-1724 | 1.83e-05 | 110 | 67 | 5 | CID000005087 | |
| Drug | AC1LCVPZ | 1.83e-05 | 110 | 67 | 5 | CID000656926 | |
| Drug | foscarnet | 2.04e-05 | 190 | 67 | 6 | CID000003414 | |
| Drug | HU-211 | 2.17e-05 | 114 | 67 | 5 | CID000107778 | |
| Drug | blebbistatin | 2.36e-05 | 116 | 67 | 5 | CID003476986 | |
| Drug | B0683 | 2.46e-05 | 117 | 67 | 5 | CID006398969 | |
| Drug | Co-protoporphyrin IX | 2.57e-05 | 118 | 67 | 5 | CID000004972 | |
| Drug | Pb m | 2.57e-05 | 118 | 67 | 5 | CID006327255 | |
| Drug | TCNB | 2.67e-05 | 119 | 67 | 5 | CID000008330 | |
| Drug | methenamine silver | 2.80e-05 | 201 | 67 | 6 | CID000004101 | |
| Drug | pentoxifylline | 3.09e-05 | 304 | 67 | 7 | CID000004740 | |
| Drug | nitroglycerin | 3.22e-05 | 206 | 67 | 6 | CID000004510 | |
| Drug | Isoproterenol | DPP7 ZNF346 DSG2 KLHL7 FARP1 SQLE ACTA1 ACTA2 KLF15 ACTG2 LDHA TRAK1 | 3.62e-05 | 1016 | 67 | 12 | ctd:D007545 |
| Drug | 2C5P | 3.65e-05 | 127 | 67 | 5 | CID000447961 | |
| Drug | NSC613009 | 4.09e-05 | 130 | 67 | 5 | CID000003800 | |
| Drug | AC1LADJ6 | 4.09e-05 | 130 | 67 | 5 | CID000486032 | |
| Drug | pyrene | 4.24e-05 | 131 | 67 | 5 | CID000031423 | |
| Drug | AC1Q6M8X | 5.10e-05 | 4 | 67 | 2 | CID000119052 | |
| Drug | auxin | 5.13e-05 | 224 | 67 | 6 | CID000000801 | |
| Drug | thalidomide | 5.80e-05 | 229 | 67 | 6 | CID000005426 | |
| Drug | NSC-351907 | 5.80e-05 | 229 | 67 | 6 | CID000004016 | |
| Drug | 0-to | 6.02e-05 | 141 | 67 | 5 | CID000002051 | |
| Drug | DE gel | 6.43e-05 | 143 | 67 | 5 | CID000008146 | |
| Drug | NSC529592 | 6.54e-05 | 234 | 67 | 6 | CID000014403 | |
| Drug | candesartan cilexetil | 6.87e-05 | 145 | 67 | 5 | CID000002540 | |
| Drug | dihydrosphingosine | 7.10e-05 | 146 | 67 | 5 | CID000003126 | |
| Drug | fluorescein isothiocyanate | 7.33e-05 | 147 | 67 | 5 | CID000018730 | |
| Drug | ML-9 | 7.33e-05 | 147 | 67 | 5 | CID000004217 | |
| Drug | AC1L1KMJ | 7.62e-05 | 476 | 67 | 8 | CID000030956 | |
| Drug | enantio-PAF-C16 | 8.23e-05 | 244 | 67 | 6 | CID000002499 | |
| Drug | carbodiimide | 8.33e-05 | 151 | 67 | 5 | CID000009864 | |
| Drug | fasudil | 8.33e-05 | 151 | 67 | 5 | CID000003547 | |
| Drug | AGEPC | 8.37e-05 | 356 | 67 | 7 | CID000461545 | |
| Drug | 6-trans-leukotriene B4 | 8.80e-05 | 247 | 67 | 6 | CID000000169 | |
| Drug | NSC339663 | 9.41e-05 | 250 | 67 | 6 | CID000003892 | |
| Drug | DFMO | 9.42e-05 | 155 | 67 | 5 | CID000003009 | |
| Drug | kinin 9 | 9.45e-05 | 363 | 67 | 7 | CID000006026 | |
| Drug | manganese | 1.00e-04 | 791 | 67 | 10 | CID000023930 | |
| Drug | ATP betaS | 1.16e-04 | 162 | 67 | 5 | CID005311341 | |
| Drug | colchine | 1.32e-04 | 383 | 67 | 7 | CID000002833 | |
| Drug | AC1L1GZB | 1.34e-04 | 167 | 67 | 5 | CID000003908 | |
| Drug | NSC350593 | 1.40e-04 | 269 | 67 | 6 | CID000004364 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.15e-09 | 8 | 61 | 4 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.15e-09 | 8 | 61 | 4 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.15e-09 | 8 | 61 | 4 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.15e-09 | 8 | 61 | 4 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 3.44e-09 | 10 | 61 | 4 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 3.44e-09 | 10 | 61 | 4 | DOID:13832 (implicated_via_orthology) | |
| Disease | Bell's palsy | 6.04e-05 | 102 | 61 | 4 | EFO_0007167 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.50e-04 | 9 | 61 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 2.28e-04 | 11 | 61 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | sleep disorder (implicated_via_orthology) | 2.28e-04 | 11 | 61 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.74e-04 | 12 | 61 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 3.76e-04 | 14 | 61 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 1.06e-03 | 774 | 61 | 7 | C0023893 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.32e-03 | 26 | 61 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | L lactate dehydrogenase measurement | 1.32e-03 | 26 | 61 | 2 | EFO_0004808 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.53e-03 | 28 | 61 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | Primary familial dilated cardiomyopathy | 1.76e-03 | 30 | 61 | 2 | cv:C0340427 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.88e-03 | 31 | 61 | 2 | DOID:9452 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NHLPLRILGYRSTME | 41 | Q8NAT2 | |
| YGRIPRGALLSMDAL | 36 | Q9ULZ3 | |
| SVLDMARHVPLYRAL | 4381 | Q9NR09 | |
| YALPHAIMRLDLAGR | 171 | P68133 | |
| VRLPVGRHMLLFNAY | 741 | Q8N7X0 | |
| YALPHAIMRLDLAGR | 171 | P62736 | |
| ALPHAIMRLDLAGRD | 171 | P63267 | |
| KYAMRDLVHRLPGGN | 931 | Q9UQB3 | |
| MLPGFLHRLLAEIRY | 311 | Q9NZ32 | |
| LLEHRYPVVMAREGR | 351 | Q9H3Z7 | |
| HILMEAAPGLLALYR | 431 | Q9BV10 | |
| YGRLGLILFDHMVPL | 311 | Q96N11 | |
| RYLMGERLGVHPLSC | 171 | P00338 | |
| MARSPGRAYALLLLL | 1 | Q14126 | |
| RERHLGLMGYQLLPL | 501 | Q14296 | |
| ILLIRGDRRLHTPMY | 46 | Q8NGE9 | |
| RRLHTPMYILLGNFA | 71 | Q8NGC7 | |
| HFALLYLEMRKGGLR | 81 | Q6ZST4 | |
| RRALMLHSDPSILGY | 1006 | O75420 | |
| RGAPGLLMAVREDLY | 376 | Q8NA75 | |
| LEDARHPLKYRMLIG | 226 | A6NHQ2 | |
| MLISDRLGYHRDVPD | 121 | Q8NCW6 | |
| GMRYHLLSPEDREEL | 266 | Q8IXQ5 | |
| MAHGDLKSYLRSLRP | 1106 | P06213 | |
| VGLDHRLRRPMYFFL | 51 | Q8NGQ2 | |
| ADPRLHARPMYIFLG | 51 | Q8NGC4 | |
| KLAHPYRAAVLRAME | 56 | Q8NDA8 | |
| GHSPDRRYAMVLFRI | 256 | Q9Y2T5 | |
| LDAGVRYLDLRIAHM | 96 | Q9NUJ7 | |
| GKMFNALIHRYRPDL | 226 | Q9UPN3 | |
| VRHPNYLGDLIMALA | 346 | O76062 | |
| REMDPRAHRFLGLLY | 56 | A6NKT7 | |
| RLHLRYEFLMLGIQP | 301 | Q9Y4D1 | |
| RGIDYILRHMPTLHR | 221 | Q8N878 | |
| LGRNMCHLRPTLRDY | 506 | Q9HCG7 | |
| RLEMYGIRLHPAKDR | 221 | Q9Y4F1 | |
| RGVLLLGDAYNMRHP | 401 | Q14534 | |
| KAEEHRGLLSIRYPM | 61 | P61163 | |
| RRGHDAPMIAYDALL | 271 | Q8NDY3 | |
| LGYALVIFEMPHLRD | 111 | P14616 | |
| YLGDRLVGRRAYHML | 21 | Q9UIH9 | |
| GALERLDYPRARMAL | 51 | Q5T4B2 | |
| LRMKYPHLVAGALAA | 171 | Q9UHL4 | |
| REMDPRAHRFLGLLY | 56 | Q7Z3J3 | |
| LELDRFMLYAHGPDL | 1016 | Q9NRR4 | |
| PHTAAYLQELGRMRK | 66 | Q6GMV3 | |
| RGMLYLHEEAFVPIL | 246 | Q5TCX8 | |
| LRSGLLNILYLHMPD | 306 | Q8IXR5 | |
| LGDDRMLGRLAQAYH | 421 | Q5UE93 | |
| YIALIAMALAHAPGR | 76 | Q13461 | |
| GYMVHRLLLAALGRR | 366 | P30876 | |
| YMRRRHLPDLAARGT | 326 | Q6ZSJ9 | |
| SLLHYLLQAMERPGR | 51 | O15130 | |
| LEHYVAAPRRMLGAP | 151 | O15524 | |
| YALPHAIMRLDLAGR | 171 | P68032 | |
| MDFLRLYLPGLHQAL | 1 | Q0VD83 | |
| MEAARDYAGALIRPL | 1 | O60543 | |
| RRYHSLGLFPMDSLA | 361 | Q9UPV9 | |
| MAFALLRPVGAHVLY | 1 | Q12870 | |
| ILDRILRAMGKAYHP | 346 | Q15654 | |
| YAAHALERLFTMRGP | 521 | P55060 | |
| RAYLCRVGMEVAPHL | 336 | Q7Z3J2 | |
| RLCPGDHYEVLMRLG | 216 | Q96MK2 | |
| LYDPLTKLVHMGRRD | 2406 | Q6N022 | |
| HRMLLPSGSLFFLRI | 81 | Q9HCK4 | |
| AALYHGMALALLSRL | 976 | Q9BWH6 | |
| LKLMARYGRLADPAV | 216 | Q9UL40 | |
| HDPDLAYRLALRAMR | 556 | Q9H7M6 | |
| FTVARYMEHRGLPLR | 806 | Q9H7M6 |